Trial Profile
Phase 2 Study of ZK-Epothilone (ZK-Epo; ZK219477) Plus Prednisone as First-line Chemotherapy in Patients With Metastatic Androgen-independent Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sagopilone (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Bayer
- 09 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2010 Planned end date changed from 1 Oct 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.